rs1058205
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000326003.7(KLK3):c.*15C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.788 in 1,585,160 control chromosomes in the GnomAD database, including 496,373 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.74 ( 42412 hom., cov: 32)
Exomes 𝑓: 0.79 ( 453961 hom. )
Consequence
KLK3
ENST00000326003.7 3_prime_UTR
ENST00000326003.7 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.170
Genes affected
KLK3 (HGNC:6364): (kallikrein related peptidase 3) Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. The gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. It encodes a single-chain glycoprotein, a protease which is synthesized in the epithelial cells of the prostate gland, and is present in seminal plasma. It is thought to function normally in the liquefaction of seminal coagulum, presumably by hydrolysis of the high molecular mass seminal vesicle protein. The serum level of this protein, called PSA in the clinical setting, is useful in the diagnosis and monitoring of prostatic carcinoma. Alternate splicing of this gene generates several transcript variants encoding different isoforms. [provided by RefSeq, Dec 2019]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 19-50860142-C-T is Benign according to our data. Variant chr19-50860142-C-T is described in ClinVar as [Benign]. Clinvar id is 1288242.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.819 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KLK3 | NM_001648.2 | c.*15C>T | 3_prime_UTR_variant | 5/5 | ENST00000326003.7 | NP_001639.1 | ||
KLK3 | NM_001030047.1 | c.*526C>T | 3_prime_UTR_variant | 5/5 | NP_001025218.1 | |||
KLK3 | NM_001030048.1 | c.*15C>T | 3_prime_UTR_variant | 5/5 | NP_001025219.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KLK3 | ENST00000326003.7 | c.*15C>T | 3_prime_UTR_variant | 5/5 | 1 | NM_001648.2 | ENSP00000314151 | P1 |
Frequencies
GnomAD3 genomes AF: 0.739 AC: 112266AN: 151962Hom.: 42398 Cov.: 32
GnomAD3 genomes
AF:
AC:
112266
AN:
151962
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.751 AC: 185689AN: 247176Hom.: 70802 AF XY: 0.753 AC XY: 100486AN XY: 133496
GnomAD3 exomes
AF:
AC:
185689
AN:
247176
Hom.:
AF XY:
AC XY:
100486
AN XY:
133496
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.793 AC: 1136113AN: 1433080Hom.: 453961 Cov.: 24 AF XY: 0.790 AC XY: 563649AN XY: 713806
GnomAD4 exome
AF:
AC:
1136113
AN:
1433080
Hom.:
Cov.:
24
AF XY:
AC XY:
563649
AN XY:
713806
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.739 AC: 112326AN: 152080Hom.: 42412 Cov.: 32 AF XY: 0.736 AC XY: 54749AN XY: 74342
GnomAD4 genome
AF:
AC:
112326
AN:
152080
Hom.:
Cov.:
32
AF XY:
AC XY:
54749
AN XY:
74342
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2092
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 29, 2020 | This variant is associated with the following publications: (PMID: 25691096) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at